Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
December 19, 2022
One in five people on the planet live in countries at risk of debt distress. Yet the leaders and institutions that understand the challenge and could address it are instead virtue signaling and pointing the finger at others who share responsibly for a solution. We need a different approach—one that ...
CGD NOTES
December 14, 2022
Ensuring rapid and equitable access to effective oral COVID-19 therapies is essential to reducing health disparities from COVID-19 and building a better response system for future epidemics and pandemics. A multipronged strategy for medical countermeasures must include antivirals, monoclonal antibod...
Blog Post
December 14, 2022
It’s clear that COVID-19 oral antivirals are effective, and recent deals have made them even cheaper for African countries. But should these countries be investing in these medicines? Or would spending on alternative health services be better value for money? Unfortunately, there is very little avai...
Blog Post
December 14, 2022
Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.
Blog Post
December 13, 2022
Earlier this year, the IMF board approved the establishment of the Resilience and Sustainability Trust (RST) to provide financial support to countries addressing long-term structural challenges, including climate change and pandemic preparedness. 143 countries are eligible to receive support from th...
CGD NOTES
December 13, 2022
The unprecedented turnout at rallies across Pakistan protesting corruption and poor job prospects underscores the frustration among the rapidly growing middle class with governance failures. Pakistan’s economic growth exceeded India’s for over four decades after its independence in 1947, but since t...
Blog Post
December 02, 2022
An important debate is taking place in Europe right now on how to fund new antimicrobials. For months it has been speculated that the European Union may move towards implementing transferable exclusivity vouchers (TEVs). In response, 14 Member States wrote to the European Commission outlining why th...
Blog Post
November 30, 2022
SDRs are only part of the answer to Africa's economic and financial challenges. But they can be mobilized quickly and responsively to meet acute needs on the continent. The cost to the United States is essentially zero. The potential benefits to African countries and US credibility are immense.
Blog Post
November 29, 2022
The Global North can make an immediate down payment on the promises made at COP27 to increase financing for emerging markets and developing countries. How can countries ensure that funding starts to flow now? By pushing the limits of the funding mechanisms already in place.